A carregar...

Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis

AIMS: To investigate the overall incidence and risk of hypertension in cancer patients who receive axitinib and compare the differences in incidences between axitinib and the other four approved vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKIs). METHODS: Several d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Qi, Wei-Xiang, He, Ai-Na, Shen, Zan, Yao, Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769663/
https://ncbi.nlm.nih.gov/pubmed/23617405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12149
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!